Home / Market News / $SFIX
benzinga Corporate Catalyst Impact 92/100 ● negative

Stitch Fix Posts Mixed Q4 Results, Joins Viking Therapeutics And Other Big Stocks Moving Lower In Thursday’s Pre-Market Session

Sep 24, 2026, 12:02 PM UTC · Primary ticker $SFIX

Stitch Fix reported mixed Q4 results, with revenue missing estimates and fiscal 2027 sales guidance falling significantly below analyst expectations. This negative outlook has led to a sharp decline in the company's pre-market share price, indicating strong investor disapproval of the future growth prospects.

Stitch Fix (SFIX) announced Q4 earnings that, while beating on EPS, missed revenue estimates and, more critically, provided significantly weaker fiscal 2027 revenue guidance than analysts anticipated. This signals a deteriorating outlook for the company's future sales, directly impacting investor confidence and leading to an 18.2% pre-market share price drop. This event is a major negative catalyst for SFIX, as it suggests fundamental business challenges or a tougher market environment. Other stocks like MGM and VKTX are also moving lower due to specific company news (withdrawn acquisition, proposed offerings, respectively), contributing to a broader negative sentiment in Thursday's pre-market session. For traders, SFIX presents a short-term downside risk due to the guidance cut, while the broader market weakness suggests caution.

$SFIX negative Mixed Q4 results, weak fiscal 2027 guidance
$MGM negative Acquisition proposal withdrawn
$VKTX negative Proposed public offerings
$ICHR negative General market downturn
$ARQQ negative General market downturn
Source: benzinga
Join the waitlist for full signal validation →

Not financial advice. AI-generated analysis for informational purposes only.